Retirement Systems of Alabama increased its stake in shares of Omega Healthcare Investors Inc. (NYSE:OHI) by 126.7% during the third quarter, according to its most recent 13F filing with the SEC. The firm owned 484,329 shares of the real estate investment trust’s stock after buying an additional 270,724 shares during the period. Retirement Systems of Alabama owned about 0.25% of Omega Healthcare Investors worth $17,169,000 as of its most recent SEC filing.
Several other hedge funds and other institutional investors also recently made changes to their positions in OHI. American National Registered Investment Advisor Inc. acquired a new position in Omega Healthcare Investors during the second quarter valued at $512,000. Sumitomo Mitsui Trust Holdings Inc. boosted its position in shares of Omega Healthcare Investors by 11.2% in the third quarter. Sumitomo Mitsui Trust Holdings Inc. now owns 135,267 shares of the real estate investment trust’s stock worth $4,795,000 after buying an additional 13,658 shares in the last quarter. Bank of Montreal Can purchased a new position in shares of Omega Healthcare Investors during the second quarter worth approximately $6,648,000. Fox Run Management L.L.C. purchased a new position in shares of Omega Healthcare Investors during the second quarter worth approximately $312,000. Finally, Aviance Capital Management LLC boosted its position in shares of Omega Healthcare Investors by 18.0% in the second quarter. Aviance Capital Management LLC now owns 222,281 shares of the real estate investment trust’s stock worth $7,546,000 after buying an additional 33,980 shares in the last quarter. 84.13% of the stock is currently owned by institutional investors.
Shares of Omega Healthcare Investors Inc. (NYSE:OHI) traded up 0.10% during trading on Friday, reaching $28.92. The company’s stock had a trading volume of 751,400 shares. Omega Healthcare Investors Inc. has a 12-month low of $26.96 and a 12-month high of $38.09. The company has a market cap of $5.64 billion, a PE ratio of 18.40 and a beta of 0.59. The company has a 50 day moving average of $31.09 and a 200 day moving average of $33.55.
Omega Healthcare Investors (NYSE:OHI) last posted its earnings results on Monday, October 31st. The real estate investment trust reported $0.80 EPS for the quarter, missing the Zacks’ consensus estimate of $0.84 by $0.04. The business earned $224.60 million during the quarter, compared to the consensus estimate of $186.35 million. Omega Healthcare Investors had a return on equity of 7.37% and a net margin of 34.53%. The firm’s revenue for the quarter was up 11.8% on a year-over-year basis. During the same period in the previous year, the business posted $0.79 EPS. On average, analysts anticipate that Omega Healthcare Investors Inc. will post $3.38 EPS for the current fiscal year.
The firm also recently announced a quarterly dividend, which was paid on Tuesday, November 15th. Shareholders of record on Monday, October 31st were issued a $0.61 dividend. This is a positive change from Omega Healthcare Investors’s previous quarterly dividend of $0.60. The ex-dividend date of this dividend was Thursday, October 27th. This represents a $2.44 dividend on an annualized basis and a dividend yield of 8.45%. Omega Healthcare Investors’s dividend payout ratio (DPR) is presently 155.42%.
A number of brokerages have recently commented on OHI. Zacks Investment Research cut Omega Healthcare Investors from a “buy” rating to a “hold” rating in a research report on Thursday, August 4th. Jefferies Group set a $35.00 price target on Omega Healthcare Investors and gave the company a “buy” rating in a research report on Friday, November 11th. TheStreet raised Omega Healthcare Investors from a “hold” rating to a “buy” rating in a research report on Friday, August 5th. Vetr raised Omega Healthcare Investors from a “hold” rating to a “buy” rating and set a $35.84 price target on the stock in a research report on Tuesday, August 2nd. Finally, JMP Securities cut Omega Healthcare Investors from an “outperform” rating to a “market perform” rating in a research report on Thursday, August 18th. They noted that the move was a valuation call. Four equities research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. The company has a consensus rating of “Buy” and a consensus price target of $36.59.
In other news, Director Bernard J. Korman purchased 100,000 shares of the company’s stock in a transaction dated Friday, November 4th. The shares were purchased at an average cost of $29.29 per share, for a total transaction of $2,929,000.00. Following the purchase, the director now directly owns 774,685 shares in the company, valued at approximately $22,690,523.65. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CEO C Taylor Pickett purchased 21,800 shares of the company’s stock in a transaction dated Friday, November 4th. The stock was purchased at an average price of $29.26 per share, for a total transaction of $637,868.00. Following the completion of the purchase, the chief executive officer now owns 276,261 shares in the company, valued at $8,083,396.86. The disclosure for this purchase can be found here. 4.54% of the stock is owned by company insiders.
Omega Healthcare Investors Company Profile